{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:36:32Z","timestamp":1786707392670,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Peiyu Project of Meizhou People\u2019s Hospital","award":["PY-C2026035"],"award-info":[{"award-number":["PY-C2026035"]}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["B2025424"],"award-info":[{"award-number":["B2025424"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13258-026-01785-5","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:23:25Z","timestamp":1780907005000},"page":"1087-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multi-omics analysis of a succinylation-associated gene-expression signature in clear cell renal cell carcinoma: prognostic significance and the immune-metabolic microenvironment"],"prefix":"10.1007","volume":"48","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-1863","authenticated-orcid":false,"given":"Huiming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"1785_CR1","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1111\/jcmm.17507","volume":"26","author":"W Bai","year":"2022","unstructured":"Bai W, Cheng L, Xiong L, Wang M, Liu H, Yu K, Wang W (2022) Protein succinylation associated with the progress of hepatocellular carcinoma. J Cell Mol Med 26:5702\u20135712","journal-title":"J Cell Mol Med"},{"key":"1785_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41581-020-0316-3","volume":"16","author":"CM D\u00edaz-Montero","year":"2020","unstructured":"D\u00edaz-Montero CM, Rini BI, Finke JH (2020) The immunology of renal cell carcinoma. Nat Rev Nephrol 16:721\u2013735","journal-title":"Nat Rev Nephrol"},{"key":"1785_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17162652","author":"J Gao","year":"2025","unstructured":"Gao J, Yu W (2025) Regulators of cancer progression: Succinylation. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17162652","journal-title":"Cancers (Basel)"},{"key":"1785_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38:675\u2013678","journal-title":"Nat Biotechnol"},{"key":"1785_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.molcel.2024.12.025","volume":"85","author":"D Guo","year":"2025","unstructured":"Guo D, Yu Q, Tong Y, Qian X, Meng Y, Ye F, Jiang X, Wu L, Yang Q, Li S et al (2025) OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. Mol Cell 85:843-856.e846","journal-title":"Mol Cell"},{"key":"1785_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"1785_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1336057","volume":"11","author":"X Hou","year":"2024","unstructured":"Hou X, Chen Y, Li X, Gu X, Dong W, Shi J, Ji S (2024) Protein succinylation: regulating metabolism and beyond. Front Nutr 11:1336057","journal-title":"Front Nutr"},{"key":"1785_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303535","volume":"10","author":"Q Hu","year":"2023","unstructured":"Hu Q, Xu J, Wang L, Yuan Y, Luo R, Gan M, Wang K, Zhao T, Wang Y, Han T et al (2023) SUCLG2 regulates mitochondrial dysfunction through succinylation in lung adenocarcinoma. Adv Sci 10:e2303535","journal-title":"Adv Sci"},{"key":"1785_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","volume":"56","author":"J Hu","year":"2024","unstructured":"Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, Li N, Zhou L, Yang Y, Wang L et al (2024) Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat Genet 56:442\u2013457","journal-title":"Nat Genet"},{"key":"1785_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S (2019) Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16:1289\u20131296","journal-title":"Nat Methods"},{"key":"1785_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","volume":"57","author":"L Liang","year":"2025","unstructured":"Liang L, Kuang X, He Y, Zhu L, Lau P, Li X, Luo D, Gong L, Zhou W, Zhang F et al (2025) Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma. Nat Genet 57:680\u2013693","journal-title":"Nat Genet"},{"key":"1785_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X (2016) Post-translational modification control of innate immunity. Immunity 45:15\u201330","journal-title":"Immunity"},{"key":"1785_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115713","volume":"168","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang R, Wang Y, Duan Y, Zhan H (2023) Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy. Biomed Pharmacother 168:115713","journal-title":"Biomed Pharmacother"},{"key":"1785_CR14","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22","DOI":"10.1093\/bib\/bbab260"},{"key":"1785_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR et al (2022) The 2022 World Health Organization classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol 82:458\u2013468","journal-title":"Eur Urol"},{"key":"1785_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (2020) Epidemiology of renal cell carcinoma. World J Oncol 11:79\u201387","journal-title":"World J Oncol"},{"key":"1785_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2018.06.003","volume":"1870","author":"DJ Sanchez","year":"2018","unstructured":"Sanchez DJ, Simon MC (2018) Genetic and metabolic hallmarks of clear cell renal cell carcinoma. Biochim Biophys Acta Rev Cancer 1870:23\u201331","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1785_CR18","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.gendis.2022.10.028","volume":"10","author":"R Shen","year":"2023","unstructured":"Shen R, Ruan H, Lin S, Liu B, Song H, Li L, Ma T (2023) Lysine succinylation, the metabolic bridge between cancer and immunity. Genes Dis 10:2470\u20132478","journal-title":"Genes Dis"},{"key":"1785_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118632","volume":"264","author":"D Singh","year":"2021","unstructured":"Singh D (2021) Current updates and future perspectives on the management of renal cell carcinoma. Life Sci 264:118632","journal-title":"Life Sci"},{"key":"1785_CR20","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R (2019) Comprehensive integration of single-cell data. Cell 177:1888-1902.e1821","journal-title":"Cell"},{"key":"1785_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P (2022) Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 13:877\u2013919","journal-title":"Protein Cell"},{"key":"1785_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41417-022-00464-3","volume":"30","author":"H Wang","year":"2023","unstructured":"Wang H, Yang L, Liu M, Luo J (2023) Protein post-translational modifications in the regulation of cancer hallmarks. Cancer Gene Ther 30:529\u2013547","journal-title":"Cancer Gene Ther"},{"key":"1785_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semnephrol.2018.01.006","volume":"38","author":"RH Weiss","year":"2018","unstructured":"Weiss RH (2018) Metabolomics and metabolic reprogramming in kidney cancer. Semin Nephrol 38:175\u2013182","journal-title":"Semin Nephrol"},{"key":"1785_CR24","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, Yuan H, Cheng P, Li F, Long Z et al (2018) TIP: A web server for resolving tumor immunophenotype profiling. Cancer Res 78:6575\u20136580","journal-title":"Cancer Res"},{"key":"1785_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang T, Xia R, Wei Y, Wei X (2022) Targeting the tumor stroma for cancer therapy. Mol Cancer 21:208","journal-title":"Mol Cancer"},{"key":"1785_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.495","volume":"7","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y (2011) Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol 7:58\u201363","journal-title":"Nat Chem Biol"},{"key":"1785_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1034605","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen Y, Fang L, Zhao J, Deng S (2022) The involvement of high succinylation modification in the development of prostate cancer. Front Oncol 12:1034605","journal-title":"Front Oncol"},{"key":"1785_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58429-7","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang N, Sun L, Zhou S, Ji C, Cui T, Chu Q, Ye J, Liang S, Ma K, Liu Y et al (2025) Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation. Nat Commun 16:3177","journal-title":"Nat Commun"},{"key":"1785_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2023.02.002","volume":"650","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yan X, Liu Y, Yang J (2023) Succinylation of CTBP1 mediated by KAT2A suppresses its inhibitory activity on the transcription of CDH1 to promote the progression of prostate cancer. Biochem Biophys Res Commun 650:9\u201316","journal-title":"Biochem Biophys Res Commun"},{"key":"1785_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s42003-025-07720-w","volume":"8","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Chen S, Su H, Meng Y, Zang C, Ning P, Hu L, Shao H (2025) CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells. Commun Biol 8:250","journal-title":"Commun Biol"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01785-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:09:55Z","timestamp":1786705795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-026-01785-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1007\/s13258-026-01785-5","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Meizhou People\u2019s Hospital (approval number 2020-CY-06).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}